![]() |
市場調查報告書
商品編碼
1961089
醫療保健供應鏈管理市場 - 全球產業規模、佔有率、趨勢、機會、預測:按產品、交付方式、最終用戶、地區和競爭對手分類,2021-2031 年Healthcare Supply Chain Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Software, Hardware, Services), By Mode of Delivery, By End user, By Region & Competition, 2021-2031F |
||||||
全球醫療保健供應鏈管理市場預計將從 2025 年的 36.7 億美元成長到 2031 年的 51.4 億美元,複合年成長率為 5.76%。
該領域策略性地管理醫療產品、數據和資金從生產商流向最終患者的整個流程。推動這一成長的關鍵因素包括迫切需要最大限度地降低營運成本,以及日益嚴格的監管要求,例如加強產品可追溯性和序列化。此外,日益成長的溫控生物製藥處理量也需要嚴格的物流管理,這進一步推動了此解決方案的應用。根據醫療保健分銷商聯盟 (HDA) 預測,到 2024 年,美國藥品經銷商的銷售額將達到 8,620 億美元,年增 10.4%。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 36.7億美元 |
| 市場規模:2031年 | 51.4億美元 |
| 複合年成長率:2026-2031年 | 5.76% |
| 成長最快的細分市場 | 軟體 |
| 最大的市場 | 北美洲 |
整合各相關人員分散的資訊科技系統存在巨大的財務和技術障礙,對市場擴張構成重大挑戰。許多醫療機構依賴孤立的資料結構,這阻礙了無縫互通性,並限制了整個供應鏈的透明度。這種缺乏整合的情況常常導致營運效率下降、需求預測不準確,並可能造成嚴重的庫存短缺和系統內過度廢棄物。
人工智慧 (AI) 和巨量資料分析在預測性物流領域的應用,正成為全球醫療保健供應鏈管理市場的主要驅動力。這些技術使相關人員能夠透過分析大量資料集來預測需求並最佳化庫存,從而從被動應對模式轉向主動策略。借助演算法洞察,企業可以透過精準的庫存管理減少營運中斷並有效控制廢棄物。這項技術進步也體現在基礎設施升級;根據醫療保健分銷聯盟 (HDA) 於 2025 年 9 月發布的第 96 版《概況介紹》,對營運效率的追求正在推動這些技術的應用,68% 的經銷商表示他們正在使用自動化解決方案來提高訂單準確性和處理速度。
同時,打擊假藥追蹤系統的需求日益成長,成為市場成長的關鍵決定因素。隨著國際貿易網路日趨複雜,製造商必須採用先進的序列化技術,以確保病患安全並遵守嚴格的法規結構。這種對安全的重視源自於持續不斷的非法活動。根據藥品安全研究所發布的《2025年報告》,2024年全球將發生6,424起涉毒犯罪案件,凸顯了確保供應鏈安全透明化的迫切性。這種複雜的環境凸顯了強大的經銷網路的重要性,並有助於主要參與者的財務成功。例如,Cencora在2024年11月公佈的會計年度收入為2,940億美元,反映了滿足此需求所需的龐大物流規模。
整合分散的資訊科技系統所帶來的巨大財務和技術挑戰,是全球醫療保健供應鏈管理市場面臨的主要阻礙因素。價值鏈上的各相關人員通常使用互不相容、缺乏互通性的平台,導致資料環境各自獨立。這種缺乏整合限制了端到端的可視性,阻礙了準確預測所需的即時資料交換。因此,各組織在最佳化營運、降低效率以及應對需求波動方面面臨許多挑戰。
這些技術脫節會導致嚴重的庫存管理失誤,直接阻礙市場成長。當資料無法在組織間順暢流動時,產業將面臨更高的缺貨和供應中斷風險,從而削弱人們對現有管理框架的信心。根據美國系統藥劑師協會 (ASHP) 統計,2024 年出現了創紀錄的 323 起嚴重藥品短缺事件。這項數據凸顯了缺乏一體化供應鏈基礎設施如何限制了確保產品穩定供應的能力,進而阻礙了整體市場發展和管理系統的實施。
向直接病患配送和居家照護模式的轉變正在重塑物流網路,將醫療服務地點從集中式醫療機構轉移到住宅。這項轉變的驅動力在於分散式臨床試驗的擴展以及對溫控生物製藥居家給藥需求的不斷成長,這使得精準的「最後一公里」低溫運輸能力至關重要。物流供應商正在擴展其基礎設施,以支援這些高頻次、個人化的患者配送服務。這種策略重組體現在關鍵業務目標中。根據2025年1月《貝克爾醫院評論》發表的報導《UPS醫療保健2025年物流戰略內幕》,UPS醫療保健的目標是利用不斷成長的居家照護需求,在2026年實現200億美元的年收入。
同時,致力於永續和環保供應鏈要求企業透過嚴格的環境、社會和管治(ESG) 策略來減少對環境的影響。相關人員正積極推動脫碳進程,例如轉向電動交通工具、採用可生物分解包裝以及最佳化路線以減少排放。這些努力正逐漸成為衡量企業成功與否的標準指標,與財務績效並駕齊驅。近期發布的業績數據也印證了這一行業範圍內的努力。根據 Cardinal Health 於 2025 年 2 月發布的 2024 會計年度環境、社會和管治(ESG) 報告,該公司已成功將其範圍 1 和範圍 2 的溫室氣體排放較 2019 年基準值降低了 17%,展現了其在實現碳中和方面取得的切實進展。
The Global Healthcare Supply Chain Management Market is projected to expand from USD 3.67 Billion in 2025 to USD 5.14 Billion by 2031, registering a CAGR of 5.76%. This sector involves the strategic oversight of the movement of medical products, data, and finances from original manufacturers to the end patient. Key drivers of this growth include the critical need to minimize operational expenses and increasing regulatory requirements for enhanced product traceability and serialization. Furthermore, the growing volume of temperature-sensitive biologics necessitates exacting logistics management, which encourages the adoption of these solutions. According to the Healthcare Distribution Alliance, U.S. pharmaceutical distributors achieved $862 billion in sales in 2024, marking a 10.4 percent increase over the prior year.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.67 Billion |
| Market Size 2031 | USD 5.14 Billion |
| CAGR 2026-2031 | 5.76% |
| Fastest Growing Segment | Software |
| Largest Market | North America |
Significant financial and technical barriers related to integrating fragmented information technology systems across various stakeholders pose a major challenge to market expansion. Many healthcare entities rely on siloed data structures that hinder seamless interoperability and restrict visibility across the entire supply chain. This lack of integration frequently leads to operational inefficiencies and inaccurate demand forecasting, which can result in severe inventory shortages or excessive waste within the system.
Market Driver
The incorporation of Artificial Intelligence (AI) and big data analytics into predictive logistics acts as a major catalyst for the Global Healthcare Supply Chain Management Market. These technologies allow stakeholders to shift from reactive models to proactive strategies by examining massive datasets for demand forecasting and inventory optimization. By utilizing algorithmic insights, organizations can reduce operational disruptions and effectively curb wastage through precise stock management. This technological evolution is reflected in infrastructure upgrades; the Healthcare Distribution Alliance's '96th Edition HDA Factbook' from September 2025 notes that the pursuit of operational efficiency has driven widespread technology adoption, with 68 percent of distributors employing automation solutions to improve order accuracy and processing speed.
Concurrently, the growing necessity to combat counterfeit pharmaceuticals via track-and-trace systems is a crucial determinant of market growth. As global trade networks become more intricate, manufacturers are required to implement advanced serialization technologies to ensure patient safety and comply with strict regulatory frameworks. This focus on security is driven by persistent illicit activities; the Pharmaceutical Security Institute reported in 2025 that the sector recorded 6,424 pharmaceutical crime incidents globally during the 2024 calendar year, emphasizing the urgent need for secure supply chain visibility. This complex environment highlights the value of robust distribution networks, contributing to the financial success of key players. For instance, Cencora reported a fiscal year revenue of $294 billion in November 2024, reflecting the massive scale of logistics needed to support these demands.
Market Challenge
The considerable financial and technical difficulties associated with integrating fragmented information technology systems represent a significant restraint on the Global Healthcare Supply Chain Management Market. Stakeholders throughout the value chain often operate on incompatible platforms that lack interoperability, resulting in siloed data environments. This absence of integration restricts end-to-end visibility, preventing the real-time data exchange required for accurate forecasting. Consequently, organizations face challenges in optimizing operations, leading to costly inefficiencies and an inability to respond swiftly to fluctuations in demand.
These technological disconnects directly hinder market growth by causing severe inventory mismanagement. When data fails to flow seamlessly between entities, the industry encounters heightened risks of stockouts and supply disruptions, which undermines confidence in existing management frameworks. According to the American Society of Health-System Pharmacists, the number of active drug shortages hit an all-time high of 323 in 2024. This statistic underscores how the lack of a cohesive supply chain infrastructure limits the ability to ensure consistent product availability, thereby stalling broader market advancement and the adoption of management systems.
Market Trends
The transition toward direct-to-patient and home care delivery models is reshaping logistics networks by moving the point of care from centralized facilities to residential settings. This evolution is driven by the expansion of decentralized clinical trials and the increasing requirement for at-home administration of temperature-sensitive biologics, necessitating precise "last-mile" cold chain capabilities. Logistics providers are subsequently scaling their infrastructure to support these high-frequency, patient-specific shipments. This strategic realignment is highlighted by major operational targets; according to Becker's Hospital Review in January 2025, in the 'Inside UPS' Healthcare 2025 logistics strategy' article, UPS Healthcare is leveraging these expanding home-based service demands to target $20 billion in annual revenue by 2026.
Simultaneously, the focus on sustainable and green supply chain initiatives is compelling organizations to minimize their environmental impact through rigorous Environmental, Social, and Governance (ESG) strategies. Stakeholders are actively decarbonizing operations by transitioning to electric transport fleets, utilizing biodegradable packaging, and optimizing route efficiency to lower emissions. These efforts are increasingly becoming a standard metric of operational success alongside financial performance. This industry-wide commitment is exemplified by recent performance data; according to Cardinal Health in February 2025, in the 'Fiscal 2024 Environmental, Social and Governance (ESG) Report', the company successfully reduced its Scope 1 and 2 greenhouse gas emissions by 17 percent from a fiscal 2019 baseline, reflecting tangible progress toward carbon neutrality.
Report Scope
In this report, the Global Healthcare Supply Chain Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Healthcare Supply Chain Management Market.
Global Healthcare Supply Chain Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: